33362.全球干细胞抗癌疗法市场报告(2012-2016年)
[医药制造业] [2013-09-30]
Stem cells are undifferentiated cells with self-renewal and differentiation properties. Stem cell products are applied in numerous permutations of methods with the usage of cells, engineering and materials, and appropriate biochemical factors. At present, stem cell-based therapies used in cancer treatment are chiefly of the hematopoietic variety, although at the research level, there is a noteworthy increase in embryonic, pluripotent, and other stem cell therapies. Currently there are no FDA-approved stem cell therapies; however there are a few FDA-approved stem cell therapies that are used adjunctively as part of an oncology therapy. These therapies have either a tissue regenerative effect, a tissue protective effect, or an anti–cancer effect. Stem cells have been used to renew the blood and immune systems impaired by cancer cells or during the treatment of cancer, i.e., by chemotherapy or radiotherapy. Apart from their use in the immunomodulation, stem cells have been proven to contribute to tissue regeneration and as delivery vehicles in the cancer treatment. The recent theory of cancer stem cells has engaged scientific communities towards a different wide new area of research field with possible potential future treatment modalities for cancer. Stem cell therapy is an emerging field and leading pharmaceutical companies are showing considerable interest in this area. Stem cells offer immense potential for treating various untreatable diseases.
关键词:干细胞;抗癌疗法;自我更新;分化